269 related articles for article (PubMed ID: 35925023)
1. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for
Assam I; Vijande J; Ballester F; Pérez-Calatayud J; Poppe B; Siebert FA
Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
[TBL] [Abstract][Full Text] [Related]
2. Development of virtual patient models for permanent implant brachytherapy Monte Carlo dose calculations: interdependence of CT image artifact mitigation and tissue assignment.
Miksys N; Xu C; Beaulieu L; Thomson RM
Phys Med Biol; 2015 Aug; 60(15):6039-62. PubMed ID: 26216174
[TBL] [Abstract][Full Text] [Related]
3. Patient-specific Monte Carlo dose calculations for (103)Pd breast brachytherapy.
Miksys N; Cygler JE; Caudrelier JM; Thomson RM
Phys Med Biol; 2016 Apr; 61(7):2705-29. PubMed ID: 26976478
[TBL] [Abstract][Full Text] [Related]
4. Improved tissue assignment using dual-energy computed tomography in low-dose rate prostate brachytherapy for Monte Carlo dose calculation.
Côté N; Bedwani S; Carrier JF
Med Phys; 2016 May; 43(5):2611. PubMed ID: 27147370
[TBL] [Abstract][Full Text] [Related]
5. Metallic artifact mitigation and organ-constrained tissue assignment for Monte Carlo calculations of permanent implant lung brachytherapy.
Sutherland JG; Miksys N; Furutani KM; Thomson RM
Med Phys; 2014 Jan; 41(1):011712. PubMed ID: 24387504
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations.
Haidari AM; Miksys N; Soubiran P; Cygler JE; Holmes O; Perry G; Thomson RM
Brachytherapy; 2019; 18(6):875-882. PubMed ID: 31400953
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric investigation of
Deering SG; Hilts M; Batchelar D; Crook J; Thomson RM
Brachytherapy; 2021; 20(3):686-694. PubMed ID: 33551273
[TBL] [Abstract][Full Text] [Related]
10. Model-based dose calculations for (125)I lung brachytherapy.
Sutherland JG; Furutani KM; Garces YI; Thomson RM
Med Phys; 2012 Jul; 39(7):4365-77. PubMed ID: 22830769
[TBL] [Abstract][Full Text] [Related]
11. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
13. egs_brachy: a versatile and fast Monte Carlo code for brachytherapy.
Chamberland MJ; Taylor RE; Rogers DW; Thomson RM
Phys Med Biol; 2016 Dec; 61(23):8214-8231. PubMed ID: 27804922
[TBL] [Abstract][Full Text] [Related]
14. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
[TBL] [Abstract][Full Text] [Related]
15. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
16. Correction of CT artifacts and its influence on Monte Carlo dose calculations.
Bazalova M; Beaulieu L; Palefsky S; Verhaegena F
Med Phys; 2007 Jun; 34(6):2119-32. PubMed ID: 17654915
[TBL] [Abstract][Full Text] [Related]
17. An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy.
Safigholi H; Sardari D; Karimi Jashni S; Mahdavi SR; Meigooni AS
J Appl Clin Med Phys; 2013 May; 14(3):4226. PubMed ID: 23652254
[TBL] [Abstract][Full Text] [Related]
18. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
Morcos M; Viswanathan AN; Enger SA
Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric impact of dual-energy CT tissue segmentation for low-energy prostate brachytherapy: a Monte Carlo study.
Remy C; Lalonde A; Béliveau-Nadeau D; Carrier JF; Bouchard H
Phys Med Biol; 2018 Jan; 63(2):025013. PubMed ID: 29260727
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
